文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.
复制论文ID
分享
摘要
作者
参考文献
暂无分享,去
创建一个
H. Hurwitz
|
J. Yi
|
O. Rosen
|
William L. Ince
|
W. Novotny
保存到论文桶